Status:
COMPLETED
FLOTOR Pilot Study
Lead Sponsor:
Oxford University Hospitals NHS Trust
Conditions:
Chylothorax
Esophageal Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
This is a non-randomised study assessing the technique of using indocyanine green as a fluorescent dye to highlight the thoracic duct during oesophectomy.
Detailed Description
The thoracic duct is the largest vessel of the lymphatic system in the body. It transports chyle (a liquid containing both lymph and emulsified fats) from most of the body, including the gastrointesti...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or above.
- Undergoing elective oesophagectomy
Exclusion
- Known allergy to iodine or ICG
- Female patient who is pregnant, planning pregnancy or breastfeeding
- Patient has a lactose intolerance (excluded only from receiving cream method)
- Known significant liver failure
Key Trial Info
Start Date :
December 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2018
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03292757
Start Date
December 20 2017
End Date
September 20 2018
Last Update
November 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Upper GI Surgery, Oxford University Hospitals
Headington, Oxfordshire, United Kingdom, OX3 7LE